Compare Stocks: DTCK, FXLV, DRMA, and WBUY

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DRMA Dermata Therapeutics	$1.12 -1.8%	$1.26	$0.95 ▼ $5.87	$4.59M	0.69	33,026 shs	25,033 shs
DTCK Davis Commodities	$1.00	$1.51	$0.60 ▼ $137.80	$1.37M	-0.03	289,589 shs	N/A
FXLV F45 Training		$0.03	$0.00 ▼ $0.20	$1.78M	0.27	12,085 shs	N/A
WBUY WeBuy Global	$0.90 +8.2%	$0.88	$0.62 ▼ $4.96	$4.56M	2.92	2.14 million shs	37.72 million shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DRMA Dermata Therapeutics	0.00%	-1.72%	-14.93%	-12.31%	-78.03%
DTCK Davis Commodities	0.00%	0.00%	0.00%	0.00%	-99.69%
FXLV F45 Training	0.00%	0.00%	0.00%	0.00%	-75.00%
WBUY WeBuy Global	0.00%	-1.78%	+0.25%	-3.13%	-76.09%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DRMA Dermata Therapeutics	$1.12 -1.8%	$1.26	$0.95 ▼ $5.87	$4.59M	0.69	33,026 shs	25,033 shs
DTCK Davis Commodities	$1.00	$1.51	$0.60 ▼ $137.80	$1.37M	-0.03	289,589 shs	N/A
FXLV F45 Training		$0.03	$0.00 ▼ $0.20	$1.78M	0.27	12,085 shs	N/A
WBUY WeBuy Global	$0.90 +8.2%	$0.88	$0.62 ▼ $4.96	$4.56M	2.92	2.14 million shs	37.72 million shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DRMA Dermata Therapeutics	0.00%	-1.72%	-14.93%	-12.31%	-78.03%
DTCK Davis Commodities	0.00%	0.00%	0.00%	0.00%	-99.69%
FXLV F45 Training	0.00%	0.00%	0.00%	0.00%	-75.00%
WBUY WeBuy Global	0.00%	-1.78%	+0.25%	-3.13%	-76.09%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DRMA Dermata Therapeutics	1.00	Sell	N/A	N/A
DTCK Davis Commodities	1.00	Sell	N/A	N/A
FXLV F45 Training	0.00	N/A	N/A	N/A
WBUY WeBuy Global	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest DTCK, FXLV, DRMA, and WBUY Analyst Ratings

Date	Company	Brokerage	Action	Rating
9/9/2026	WBUY WeBuy Global	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/26/2026	WBUY WeBuy Global	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/12/2026	WBUY WeBuy Global	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/28/2026	DRMA Dermata Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (E+)
7/10/2026	DRMA Dermata Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (E+) ➝ Sell (E)

(Data available from 9/28/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DRMA Dermata Therapeutics	N/A	N/A	N/A	N/A	$2.19 per share	N/A
DTCK Davis Commodities	$160.53M	0.01	N/A	N/A	$5.49 per share	0.18
FXLV F45 Training	$171.19M	0.00	N/A	N/A	N/A	NaN
WBUY WeBuy Global	$18.83M	0.26	N/A	N/A	$1.35 per share	0.67

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DRMA Dermata Therapeutics	-$7.56M	-$4.39	N/A	N/A	N/A	N/A	-166.66%	-130.13%	11/18/2026 (Estimated)
DTCK Davis Commodities	-$3.53M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FXLV F45 Training	-$178.80M	-$0.47	N/A	N/A	N/A	N/A	N/A	N/A	N/A
WBUY WeBuy Global	-$8.53M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Latest DTCK, FXLV, DRMA, and WBUY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/11/2026	Q2 2026	DRMA Dermata Therapeutics	-$0.55	-$0.74	-$0.19	-$0.74	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DRMA Dermata Therapeutics	N/A	N/A	N/A	N/A	N/A
DTCK Davis Commodities	N/A	N/A	N/A	N/A	N/A
FXLV F45 Training	N/A	N/A	N/A	N/A	N/A
WBUY WeBuy Global	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DRMA Dermata Therapeutics	N/A	2.81	2.73
DTCK Davis Commodities	0.02	1.02	1.02
FXLV F45 Training	N/A	N/A	N/A
WBUY WeBuy Global	N/A	1.15	1.15

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DRMA Dermata Therapeutics	8.67%
DTCK Davis Commodities	81.83%
FXLV F45 Training	0.05%
WBUY WeBuy Global	0.34%

Insider Ownership

Company	Insider Ownership
DRMA Dermata Therapeutics	21.90%
DTCK Davis Commodities	N/A
FXLV F45 Training	62.10%
WBUY WeBuy Global	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DRMA Dermata Therapeutics	9	4.02 million	3.14 million	Not Optionable
DTCK Davis Commodities	22	1.37 million	N/A	Not Optionable
FXLV F45 Training	160	98.91 million	37.49 million	No Data
WBUY WeBuy Global	109	5.48 million	N/A	Not Optionable

DTCK, FXLV, DRMA, and WBUY Headlines

Recent News About These Companies

Webuy Global revenue nearly doubles in first half of 2026

4 hours ago | streetinsider.com

WEBUY GLOBAL nearly doubles first-half 2026 revenue as gross profit rises 131.7%

September 28 at 2:35 PM | msn.com

Why Webuy Global Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

September 28 at 5:29 AM | benzinga.com

WEBUY GLOBAL LTD. Nearly Doubles First-Half 2026 Revenue to US$14.3 Million as Gross Profit Increases 132%

September 28 at 4:30 AM | globenewswire.com

WeBuy Global (NASDAQ:WBUY) Shares Down 0.8% - What's Next?

September 23, 2026 | americanbankingnews.com

Webuy Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

September 18, 2026 | globenewswire.com

WBUY - Webuy Global Ltd

September 1, 2026 | seekingalpha.com

Why Webuy Global Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket

August 31, 2026 | benzinga.com

WEBUY GLOBAL LTD. Reports Record NATAS Fair Bookings of US$ 4.76 Million, 42% Higher than March 2026

August 31, 2026 | globenewswire.com

Travel Tech Play Soars on a Bet on China's Inbound Tourism Reopening

July 25, 2026 | msn.com

Webuy Expands China Inbound Tourism Partnerships Through PATA Membership

July 24, 2026 | finance.yahoo.com

Webuy Global Targets China Inbound Tourism Boom with New Partnerships

July 23, 2026 | benzinga.com

Webuy Strengthens Its Position in China's Growing Inbound Tourism Market Through Strategic Industry Partnerships

July 23, 2026 | globenewswire.com

Webuy Expands China Inbound Travel Capabilities Through Strategic Partnership with Moyu Travel and MeetPanda

July 20, 2026 | globenewswire.com

Webuy Launches AI Agent-Assisted Smart Travel Card to Enhance Connected Travel Experience

July 13, 2026 | globenewswire.com

Webuy Global Ltd - Ordinary Shares - Class A

July 1, 2026 | money.usnews.com

Webuy Global Awards CEO Share-Based Pay and Sells High-Vote Stock in April 2026 Deals

April 26, 2026 | theglobeandmail.com

Webuy Logs $3.34 Million in Bookings at Singapore Travel Expo

April 23, 2026 | finance.yahoo.com

WEBUY GLOBAL LTD. Announces Record-Breaking Performance For the Company at NATAS Fair March 2026 with Over US$3.34 Million in Travel Bookings

April 22, 2026 | globenewswire.com

Webuy Global Ltd.

April 20, 2026 | edition.cnn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

DTCK, FXLV, DRMA, and WBUY Company Descriptions

Dermata Therapeutics NASDAQ:DRMA

$1.12 -0.02 (-1.75%)

Closing price 03:59 PM Eastern

Extended Trading

$1.12 0.00 (0.00%)

As of 07:46 PM Eastern

Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of anxillary hyperhidrosis and aesthetic conditions. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Davis Commodities NASDAQ:DTCK

Davis Commodities Limited, an investment holding company, operates as an agricultural commodity trading company in Asia, Africa, and the Middle East. The company trades in agricultural commodities, including sugar, rice, and oil and fat products under the Maxwill and Taffy brands. It also provides warehouse storage and logistic, as well as agency services. Davis Commodities Limited was founded in 1999 and is headquartered in Singapore. The company operates as a subsidiary of Davis & KT Holdings Pte. Ltd.

F45 Training NYSE:FXLV

F45 Training Holdings Inc. operates as a fitness franchisor. The company offers consumers functional 45-minute workouts that combine elements of high-intensity interval, circuit, and functional training. It provides workouts primarily through its digitally-connected network of studios. It has operations in the United States, South America, Australia, New Zealand and surrounding island nations, and internationally. The company was formerly known as Flyhalf Holdings Inc. and changed its name to F45 Training Holdings Inc. in March 2019. F45 Training Holdings Inc. was founded in 2013 and is headquartered in Austin, Texas.

WeBuy Global NASDAQ:WBUY

$0.90 +0.07 (+8.16%)

Closing price 04:00 PM Eastern

Extended Trading

$0.92 +0.02 (+2.33%)

As of 07:59 PM Eastern

Webuy Global Ltd operates as an e-commerce retailer company in Singapore, Indonesia, and Malaysia. The company sells food and beverages, fresh produces, lifestyle daily essential items, e-vouchers, miscellaneous daily needs products, and other personal care products, as well as sells packaged tours. Webuy Global Ltd was founded in 2019 and is based in Singapore.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest DTCK, FXLV, DRMA, and WBUY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest DTCK, FXLV, DRMA, and WBUY Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

DTCK, FXLV, DRMA, and WBUY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

DTCK, FXLV, DRMA, and WBUY Company Descriptions

Dermata Therapeutics NASDAQ:DRMA

Davis Commodities NASDAQ:DTCK

F45 Training NYSE:FXLV

WeBuy Global NASDAQ:WBUY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest DTCK, FXLV, DRMA, and WBUY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest DTCK, FXLV, DRMA, and WBUY Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

DTCK, FXLV, DRMA, and WBUY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

DTCK, FXLV, DRMA, and WBUY Company Descriptions

Dermata Therapeutics NASDAQ:DRMA

Davis Commodities NASDAQ:DTCK

F45 Training NYSE:FXLV

WeBuy Global NASDAQ:WBUY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools